filmov
tv
Adjuvant Therapy in Locally Advanced Pancreatic Cancer
Показать описание
John L. Marshall, MD; Tanios S. Bekaii-Saab, MD; Eileen M. O’Reilly, MD; Kabir Mody, MD; and George P. Kim, MD, review the role of adjuvant modified FOLFIRINOX versus gemcitabine in patients with resected locally advanced pancreatic adenocarcinoma and comment on dose modifications to avoid toxicities.